Teirza Bristow
Primary Care · Kellogg, IDNPI 1700363348
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 231 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 27.1% of the total. Among primary care clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$490
- GSK$396
- Pfizer$289
- Novo Nordisk$274
- Lilly USA, LLC$209
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,986100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $1,081 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $490 |
| GSK | 30 | $396 |
| Pfizer | 16 | $289 |
| Novo Nordisk | 16 | $274 |
| Lilly USA, LLC | 14 | $209 |
| Mylan Specialty L.p. | 7 | $161 |
| Amgen | 8 | $149 |
| Otsuka America Pharmaceutical, Inc. | 6 | $116 |
| Boehringer Ingelheim | 3 | $90 |
| Bayer | 5 | $82 |
| Exact Sciences | 3 | $73 |
| Sunovion Pharmaceuticals Inc. | 4 | $70 |
| Amarin Pharma, Inc. | 3 | $61 |
| AstraZeneca | 4 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Novartis | 2 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Johnson & Johnson | 2 | $36 |
| Eisai Inc. | 2 | $35 |
| Sanofi-aventis U.S. LLC | 1 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Viatris Specialty LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Corium, LLC | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$3,986 in reported general payments places this provider in the 90th percentile of 48 primary care providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $62,541 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 68 | $56,513 |
| EliquisApixaban | 26 | $35,895 |
| JardianceEmpagliflozin | 30 | $31,920 |
| Aimovig AutoinjectorErenumab-Aooe | 15 | $16,499 |
| Tresiba Flextouch U-200Insulin Degludec | 25 | $16,395 |
| Nurtec OdtRimegepant Sulfate | 14 | $16,388 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $10,757 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $8,977 |
| VascepaIcosapent Ethyl | 27 | $8,860 |
| MyrbetriqMirabegron | 13 | $5,732 |
| TrintellixVortioxetine Hydrobromide | 12 | $5,441 |
| Eletriptan HbrEletriptan Hydrobromide | 13 | $5,409 |
| BelsomraSuvorexant | 12 | $5,180 |
| Ventolin HfaAlbuterol Sulfate | 48 | $4,435 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $396 | $65,48987 claims |
| Novo NordiskOzempic | $274 | $62,54145 claims |
| PfizerEliquis, Nurtec Odt | $289 | $52,28340 claims |
| Boehringer IngelheimJardiance | $90 | $31,92030 claims |
| AstraZenecaBreztri Aerosphere | $59 | $10,75717 claims |
| AbbVieSynthroid | $1,081 | $1,24523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 48 primary care providers in Idaho.
Other primary care in Kellogg
- Bradley RadfordIdaho Falls$8K
- Kathryn NielsenIdaho Falls$5K
- Jessica ButterfieldBoise$5K
- Lynnette KhandakerBoise$4K
- Justin RogersIdaho Falls$3K
- Billie Sue MayoNampa$2K
- Marquee RicksRexburg$2K
- Helene EdmoLava Hot Springs$2K
- Brianna CracoliceNampa$2K
- Julie FrandenMeridian$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.